拉米夫定

C₈H₁₁N₃O₃S

229.26

MFCD00869739

NA.24

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Lamivudine is a potent nucleoside analog reverse transcriptase inhibitor (nRTI). It is an analogue of cytidine, and can inhibit both types (1 and 2) of HIV reverse transcriptase as well as the reverse transcriptase of hepatitis B. It needs to be phosphorylated to its triphosphate form before it is active. 3TC-triphosphate also inhibits cellular DNA polymerase.

Sales restrictions may apply.

pharmaceutical primary standard

BP

neat

2-8℃

NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2

1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1

JTEGQNOMFQHVDC-NKWVEPMBSA-N

Unit quantity: 200 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

GHS08

Warning

H361

P280

Repr. 2

13 - Non Combustible Solids

WGK 3